Biomarkers in Drug Development#

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Imaging Biomarkers in Drug Development

Imaging Biomarkers in Drug Development

The price tag of drug development has steadily increased over the years with it now costing an average of $1.3 billion and ten years to bring a new drug to market. These staggering numbers play a significant role in the rising price of drugs. For example, the anti-cancer drug, bevacizumab costs about $50,000 for one year’s treatment. This contributes to the unsustainable rise in healthcare expense and leads to increasing pressure to reduce the costs of drug development.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations

GET THE APP